Search
for
Sort by
Research 30 of 93
- Metoprolol and alopecia.
- Metoprolol
- Metoprolol-spironolactone combination for coronary heart disease with concurrent heart failure: impact on cardiac function
- Drugs and Hair Loss
- Case 4-2012
- Alopecia and drug eruption of the scalp associated with a new beta-blocker, nadolol.
- Catecholaminergic neurons boost fibroblast osteogenic activity in keloid
- Anti-anginal and beta-adrenoceptor blocking drugs
- Volume 1982, No. 4 February 26, 1982
- Intestinal Permeability Study of Minoxidil: Assessment of Minoxidil as a High Permeability Reference Drug for Biopharmaceutics Classification
- Follicular cysts and hyperkeratoses in early mycosis fungoides
- Absorption sites of orally administered drugs in the small intestine
- Psychotropic Medication and Drug-Related Alopecia
- Ovarian Hilus-Cell Hyperplasia and High Serum Testosterone in a Patient With Postmenopausal Virilization
- Telogen Effluvium
- Drug-Induced Hair Loss and Hair Growth
- Drug Reactions Affecting Hair: Diagnosis
- Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study
- DRUG‐ASSOCIATED ALOPECIA
- Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors
- Drug-Induced Hair Disorders
- Potassium channel openers: therapeutic potential in cardiology and medicine
- Hair Loss in Systemic Disease
- CUTANEOUS SIDE-EFFECTS OF BETA-ADRENERGIC BLOCKERS
- Systemic causes of hair loss
- Long COVID syndrome: An unfolding enigma
- INDUCTION OF PSORIASIFORM CHANGES IN GUINEA PIG SKIN BY PROPRANOLOL
- Oral medications for central serous chorioretinopathy: a literature review
- A falling out following minoxidil: Telogen effluvium
- Frequency and associated factors of hair loss among patients with inflammatory bowel disease